Jesus Corria-Osorio

MD PhD Oncoimmunologist @Ludwig_Cancer @OncoUNILCHUV Proud Cuban, proud physician, developing next-generation ACT for cancer immunotherapy in Switzerland

[Geneva Centre for Inflammation Research @GCIR_Unige]

#ID2024 Immunology Day in Geneva is happening now!

We're enjoying great presentations from biotech & @unige_en research groups, including brilliant keynote speaker Prof George Coukos 🙏 @CoukosGeorge @Ludwig_Cancer @OncoUNILCHUV

#Vaccines #Immunotherapy
Stay tuned for more!

[Jesus Corria-Osorio @CorriaJesus]

@iannaconelab @CellCellPress Hi , excellent paper !!! Congrats . If posible , one question . The Td-SL cells look very much similar to canonical Tpex . Could you please develop a little bit about the differentially expressed markers than make them unique ? Many thanks and congrats again .

[Jesus Corria-Osorio @CorriaJesus]

@Ludwig_Cancer @OncoUNILCHUV @Johanna_A_Joyce @EACRnews Congrats . Well deserved!!!

[Ian Parish @IanParish_AU]

Big thanks to Katharine Block & Steve Jameson @Jamequistlab for this brilliant and thoughtful commentary on our recent @ImmunityCP paper. You’ve summarized it better than I could! https://t.co/zfDt8wSKws

[Eric Topol @EricTopol]

"The maximal lifespan [of people and 347 mammalian species] is strongly associated with an epigenetic signature that is largely independent of sex, body mass, calorie restriction, or other lifestyle factors"
@ScienceAdvances
https://t.co/kk7DgGcbwr @prof_horvath and colleagues

[Waggoner Lab @LabWaggoner]

Cellular architecture is a predeterminant of early TCR signaling and subsequent cell fate decisions of individual naïve T cells in response to antigen @ScienceMagazine @BenHalePhD @BerendSnijder
https://t.co/rtwbRnkaD9

[Santiago Carmona 🧬 🖥️ @carmonation]

The under-appreciated non-linear effects of transcription factors dosing on cell fate.
Fascinating work presented by @BartDeplancke at today's @ISBSIB single-cell focus group meeting.
Exciting research directions ahead.
https://t.co/qrZ9apIs6d

[Santiago Carmona 🧬 🖥️ @carmonation]

Happy to share an exciting work from the lab in collaboration with François Kuonen and team!
Many studies have established the impact of wounding on early steps of tumor initiation. However, little is known about the effect of wounding on progression of established human tumors.

[Michael Ferguson 🧠😇🕊 @neuromichael]

Previously unseen details of human brain structure revealed. Featured image: a single neuron with ~5,600 of the nerve fibers that connect to it.

I feel overwhelming awe at nature's complexity and order.

https://t.co/lLiEo6z1YQ

[Jesus Corria-Osorio @CorriaJesus]

@GfellerD Congrats!!!

[David Gfeller @GfellerD]

Thanks!

[OncoDaily @oncodaily]

The results of our study on the effect of prostaglandin E2 on T cells - @MMorotti (@Ludwig_Cancer / @chuvlausanne)

https://t.co/2aMS5hR3ba

@AlizeeGrimm @DangajD @KnolleLab @JBoettcherLab @PCHo_Lab @vannini_lab @CorriaJesus @Conrad_Lab @hecarho

#oncodaily #oncology #cancer #research #prostaglandinE2 #Tcells #immunotherapy #IL2 #cancerresearch #Naturepublication #therapeuticimpact #collaboration #gratitude

[Jan Böttcher @JBoettcherLab]

We are thrilled that our study on PGE2-mediated impairment of TCF1+ stem-like CD8+ T cell responses in cancer, with (twitterless) Sebastian Lacher as first author, is now published @Nature! 👇 a short 🧵 below!
https://t.co/yxHgMZXS3Y

[Matteo Morotti @MMorotti]

Proud to share the results of our study on the effect of prostaglandin E2 on T cells, which was just published in Nature in which we discovered a new role for PGE2 in inhibiting interleukin-2 (IL-2) sensing and signalling in tumor-reactive T cells https://t.co/9Pu6cy0JvA

[Jesus Corria-Osorio @CorriaJesus]

@MMorotti @AlizeeGrimm @DangajD @KnolleLab @JBoettcherLab @CoukosGeorge @PCHo_Lab @vannini_lab Congrats again @MMorotti and team . Many thanks for the opportunity to collaborate. This is a wonderful story !!!

[Evan Weber @EvanWeberPhD]

Memory genes are enriched in CAR T cells that persist and control tumors in patients. But which transcription factors drive beneficial memory programs?

We answer this in our lab’s first paper in @Nature led by @alexdoan96 @kpmueller1 @andy_yhchen. 1/

https://t.co/qvTdqoeduz

[Jesus Corria-Osorio @CorriaJesus]

@EvanWeberPhD @Nature @alexdoan96 @kpmueller1 @andy_yhchen Great . Many thanks .

[Jesus Corria-Osorio @CorriaJesus]

@OncoUNILCHUV @SciImmunology @CoukosGeorge @DangajD @Ludwig_Cancer @unil @CHUVLausanne Excellent work !!! Congrats to all . Best

[Oncology UNIL CHUV @OncoUNILCHUV]

💡NEW study from Barras et al. in melanoma patients shows T cell-myeloid cellular networks mediate response to adoptive T cell therapy, in @SciImmunology
#CancerResearch #cancerday
@CoukosGeorge @DangajD @Ludwig_Cancer @unil @CHUVLausanne
➡️https://t.co/SDhdJHcHNR